http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105796503-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate | 2014-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105796503-B |
| titleOfInvention | A kind of saxagliptin pellet and its preparation |
| abstract | The present invention relates to field of pharmaceutical preparations, in particular to a kind of saxagliptin pellet and its preparation.The saxagliptin pellet is successively made of capsule core, the first separation layer, medicated layer and the second separation layer from inside to outside；Second separation layer contains coating material, and coating material is Utech or ethyl cellulose.Pellet stability provided by the invention improves, and related content of material increases slower, shelf-stable；Pellet provided by the invention has good slow release effect, so that blood concentration is rapidly reached therapeutic effect after taking, but also can maintain longer action time, blood concentration is steady, favorable reproducibility, and adverse reaction rate is low；Convenient for control quality when pellet provided by the invention produces, good appearance, good fluidity, dust is few. |
| priorityDate | 2014-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 169.